U.S. Dna Microarray Market Size & Outlook, 2022-2030
U.S. dna microarray market, 2018-2030 (US$M)
Related Markets
U.S. dna microarray market highlights
- The U.S. dna microarray market generated a revenue of USD 843.8 million in 2022 and is expected to reach USD 1,552.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.9% from 2023 to 2030.
- In terms of segment, oligonucleotide dna microarrays was the largest revenue generating type in 2022.
- Complementary DNA Microarrays is the most lucrative type segment registering the fastest growth during the forecast period.
Dna microarray market data book summary
| Market revenue in 2022 | USD 843.8 million |
| Market revenue in 2030 | USD 1,552.1 million |
| Growth rate | 7.9% (CAGR from 2022 to 2030) |
| Largest segment | Oligonucleotide dna microarrays |
| Fastest growing segment | Complementary DNA Microarrays |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Complementary DNA Microarrays, Oligonucleotide DNA Microarrays |
| Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Roche Holding AG, Agilent Technologies, Merck KGaA, BioMerieux SA, PerkinElmer, Advanced Micro Devices Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 46.0% of the global dna microarray market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. dna microarray market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 103.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Microarray Market Scope
DNA Microarray Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. dna microarray market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna microarray market will help companies and investors design strategic landscapes.
Oligonucleotide dna microarrays was the largest segment with a revenue share of 72.14% in 2022. Horizon Databook has segmented the U.S. dna microarray market based on complementary dna microarrays, oligonucleotide dna microarrays covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. DNA Microarray Type Outlook (Revenue, USD Million, 2018-2030)
- Complementary DNA Microarrays
- Oligonucleotide DNA Microarrays
- Others
- U.S. DNA Microarray Application Outlook (Revenue, USD Million, 2018-2030)
- Gene Expression Analysis
- Genotyping
- Others
- U.S. DNA Microarray End-user Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical and Biotechnology Companies
- Diagnostic Centers
- Hospitals and Clinics
- Academic and Research Institute
- Others
Reasons to subscribe to U.S. dna microarray market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. dna microarray market databook
-
Our clientele includes a mix of dna microarray market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. dna microarray market, including forecasts for subscribers. This country databook contains high-level insights into U.S. dna microarray market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. dna microarray market report size, by type, 2018-2030 (US$M)
U.S. DNA Microarray Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
